These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23904274)

  • 1. Extensive expertise in endocrinology: UK stance on adult GH replacement: the economist vs the endocrinologist.
    Shalet SM
    Eur J Endocrinol; 2013 Oct; 169(4):R81-7. PubMed ID: 23904274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
    Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
    Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.
    He X; Barkan AL
    Pituitary; 2020 Jun; 23(3):294-306. PubMed ID: 32060708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
    Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
    Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture incidence in GH-deficient patients on complete hormone replacement including GH.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Engström BE; Ekman B; Thorngren KG; Hagmar L; Erfurth EM
    J Bone Miner Res; 2007 Dec; 22(12):1842-50. PubMed ID: 17725379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Edén Engström B; Ekman B; Norrving B; Hagmar L; Erfurth EM
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3560-7. PubMed ID: 17623762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing's disease.
    Boguszewski CL
    Pituitary; 2022 Oct; 25(5):760-763. PubMed ID: 35552989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of growth hormone replacement for GH-deficient adults in Scotland.
    Philip S; Howat I; Carson M; Booth A; Campbell K; Grant D; Patterson C; Schofield C; Bevan J; Patrick A; Leese G; Connell J
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):571-6. PubMed ID: 22901318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
    Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
    Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of IGF1 estimation in adults with GH deficiency.
    Mukherjee A; Shalet SM
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S33-9. PubMed ID: 19684059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
    Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
    Klose M; Jonsson B; Abs R; Popovic V; Koltowska-Häggström M; Saller B; Feldt-Rasmussen U; Kourides I
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S75-83. PubMed ID: 19684053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
    Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
    J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
    Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
    Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
    Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Program of Severe Growth Hormone Deficiency Treatment in Adults and Adolescents after Completion of Growth Promoting Therapy.
    Lewiński A; Smyczyńska J; Stawerska R; Hilczer M; Stasiak M; Bednarczuk T; Bolanowski M; Junik R; Ruchała M; Syrenicz A; Walczak M; Zgliczyński W; Karbownik-Lewińska M
    Endokrynol Pol; 2018; 69(5):468-524. PubMed ID: 30117531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.